GLAUCOMA

This study looks at whether combining two different minimally invasive glaucoma surgeries (MIGS) works better than cataract surgery alone to lower eye pressure. Researchers will review records of 100 patients with open-angle glaucoma who had both the Hydrus microstent and iTrack …

This study tests a new surgical implant called VividWhite (VW-51) for people with glaucoma. The goal is to safely lower eye pressure and reduce the need for eye drops. 65 participants will be followed for 12 months to see if the implant works and is safe.

This early study tests a new device called eyeValve for people with glaucoma whose eye pressure stays high despite using eye drops. The device is designed to drain fluid from the eye to lower pressure. Ten adults aged 18 to 90 with advanced glaucoma will be enrolled to check if t…

This study tests a new treatment for glaucoma, a disease that damages the optic nerve and can lead to blindness. Researchers implant a small device that releases a protective protein into the eye. The goal is to see if it can slow vision loss over two years. About 30 people with …

This pilot study tests whether placing a slow-release steroid implant (Yutiq) during glaucoma drainage surgery can reduce scarring and better control eye pressure. Five adults with glaucoma will receive the implant along with a standard glaucoma valve. Researchers will compare th…

This study tests a tiny device called MINIject that is placed in the eye to help drain fluid and lower pressure in people with open-angle glaucoma. About 975 adults aged 46 and older who have had cataract surgery are taking part. The goal is to see if the implant safely reduces e…

This study tests whether a device that delivers gentle electrical stimulation to the eyes, used at home, can safely slow vision loss in people with open-angle glaucoma. The trial includes 45 adults with moderate to advanced vision damage. Researchers will measure changes in their…

This study tests a tiny implant that releases helpful cells inside the eye to protect vision in people with glaucoma. 54 participants receive either the implant or a sham procedure. The main goal is to see if the implant slows worsening of the visual field over 6 months.

This study follows 23 people who received a special lens implant that slowly releases glaucoma medication during cataract surgery. Researchers want to see if the implant keeps eye pressure low and vision clear for up to 7 years. Participants already completed an earlier study and…

This study tests a new eye drop called BL1107 against a standard treatment (timolol) in 252 adults with glaucoma or high eye pressure. The goal is to see if BL1107 is safe and improves vision better than the current option. Participants will use the drops for about a month and ha…

This study tests whether special contact lenses with built-in sensors can safely and accurately measure eye pressure continuously for 24 hours. Researchers will compare the smart lens readings to standard eye pressure tests in 120 adults, including those with glaucoma and healthy…

This study tests whether a computer-based AI teaching tool can help glaucoma patients understand and perform a key eye test (visual field test) more accurately. About 80 English-speaking adults with glaucoma will use the tool before their test. If it works, patients may need fewe…

This study looks at 116 adults who had glaucoma stent surgery up to 2 years ago. Researchers use a special eye scan to see if the tiny stents are correctly positioned and how that affects eye pressure. The goal is to learn how often stents move out of place and what that means fo…

This study offers free vision screenings to underserved adults over 40 living in affordable housing in Harlem and Washington Heights. The goal is to find eye problems like glaucoma, cataracts, and diabetic retinopathy early and connect people with follow-up care. About 749 partic…

This study measures how healthy people see in different parts of their vision. Researchers will use this data to train an artificial intelligence system to make glaucoma testing more accurate. About 100 healthy adults aged 18 and older will take a vision test. No treatment or med…

This study tests whether AI software can help eye doctors diagnose four common eye diseases—diabetic retinopathy, age-related macular degeneration, retinal vein occlusion, and glaucoma—more accurately and quickly. Ten doctors will review eye images with and without AI assistance.…

This study looks at how patients with chronic eye diseases like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are doing after their treatments. Researchers will track changes in eye pressure, vision, and other measures over time. The goal is to unders…